Skip to content
Horizon3BioTech
  • Investor Resources
  • Team
  • Resources
    • Podcasts
  • Portfolio
  • FAQ
  • Contact
  • Subscribe
  • Investor Resources
  • Team
  • Resources
    • Podcasts
  • Portfolio
  • FAQ
  • Contact
  • Subscribe

Blog

Accessing US markets – Nasdaq and FDA approval

https://www.buzzsprout.com/1763087/8378926-accessing-us-markets-nasdaq-and-fda-approval.mp3

Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt will be joined by Opthea CEO & Managing Director Dr Megan Baldwin and Phamaxis CEO Gary Phillips.

Read more articles

Previous PostEpisode 6 – Investing in Biotech
Next PostTopical investment strategies in biotech

Recent Posts

  • Episode 13 – Investing in Biotech
  • Episode 12 – Investing in Biotech
  • Investing in Biotech
  • BioBullets: The Great Dispersion
  • Episode 11 – Investing in Biotech
  • Episode 10 – Investing in Biotech
  • Episode 9 – Investing in Biotech
  • BioBullets: The Aduhelm FDA approval controversy
  • Episode 8 – Investing in Biotech
  • Episode 7 – Investing in Biotech
  • Introduction to Horizon 3
  • Topical investment strategies in biotech
  • Investor Resources
  • Team
  • Resources
  • Portfolio
  • FAQ
  • Contact
  • Subscribe
  • Disclaimer
Copyright 2020 - Horizon3Biotech